acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix]
- RxCUI
- 1190201
- RxNorm name
- acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix]
- Display name
- TREZIX (Oral Pill)
- Full name
- acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix]
- Term type
- SBD
- Status
- Active
- Strength
- 320.5-30-16 mg
- Dose form
- Cap
- Route
- Oral Pill
- Updated
- 2026-07-20 06:51:48
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 112011
- Active start
- 112011
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| acetaminophen | 320.5 MG / 1 EACH | acetaminophen | acetaminophen |
| caffeine | 30 MG / 1 EACH | caffeine | caffeine |
| dihydrocodeine bitartrate | 16 MG / 1 EACH | dihydrocodeine | dihydrocodeine bitartrate |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Capsule | 316965 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| acetaminophen | 161 |
| caffeine | 1886 |
| dihydrocodeine | 23088 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | APAP 320.5 MG / Caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix] | NAMES |
| RxNorm Name | acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix] | NAMES |
| RxNorm Synonym | APAP 320.5 MG / Caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix] | NAMES |
| RxNorm Synonym | Trezix (acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG) Oral Capsule | NAMES |
| TTY | SBD | ATTRIBUTES |
| SPL_SET_ID | 45c3c2a1-6a89-471e-b6d4-5a4cd73b987a | CODES |
| RxCUI | 1190201 | CODES |
| MMSL_CODE | BD30013 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 63187-705-00 | 63187-705 | Trezix acetaminophen, caffeine, dihydrocodeine bitartrate | Proficient Rx LP | ANDA204785 |
| 63187-705-30 | 63187-705 | Trezix acetaminophen, caffeine, dihydrocodeine bitartrate | Proficient Rx LP | ANDA204785 |
| 63187-705-60 | 63187-705 | Trezix acetaminophen, caffeine, dihydrocodeine bitartrate | Proficient Rx LP | ANDA204785 |
| 63187-705-72 | 63187-705 | Trezix acetaminophen, caffeine, dihydrocodeine bitartrate | Proficient Rx LP | ANDA204785 |
| 63187-705-90 | 63187-705 | Trezix acetaminophen, caffeine, dihydrocodeine bitartrate | Proficient Rx LP | ANDA204785 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA204785 | 63187-705 | Trezix acetaminophen, caffeine, dihydrocodeine bitartrate | ANDA | Proficient Rx LP |
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Trezix | ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE | Proficient Rx LP | 45c3c2a1-6a89-471e-b6d4-5a4cd73b987a | 2022-05-02 | Boxed warning, Warnings, Adverse reactions | 63187-705-60 63187-705-00 63187-705-90 63187-705-72 63187-705-30 63187-705 63187070572 63187070500 63187070530 63187070590 63187070560 1190201 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a519a201-bcfd-4029-9bdf-fc3e03f975ac | acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix] | SBD | 12 | TREZIX™ Capsules | 20210203 |
| a519a201-bcfd-4029-9bdf-fc3e03f975ac | Trezix (acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG) Oral Capsule | SY | 12 | TREZIX™ Capsules | 20210203 |
| a519a201-bcfd-4029-9bdf-fc3e03f975ac | APAP 320.5 MG / Caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix] | SY | 12 | TREZIX™ Capsules | 20210203 |
| a519a201-bcfd-4029-9bdf-fc3e03f975ac | TREZIX 16 MG / 320.5 MG / 30 MG Oral Capsule | PSN | 12 | TREZIX™ Capsules | 20210203 |
| 45c3c2a1-6a89-471e-b6d4-5a4cd73b987a | APAP 320.5 MG / Caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix] | SY | 6 | TREZIX™ Capsules | 20220502 |
| 45c3c2a1-6a89-471e-b6d4-5a4cd73b987a | Trezix (acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG) Oral Capsule | SY | 6 | TREZIX™ Capsules | 20220502 |
| 45c3c2a1-6a89-471e-b6d4-5a4cd73b987a | acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix] | SBD | 6 | TREZIX™ Capsules | 20220502 |
| 45c3c2a1-6a89-471e-b6d4-5a4cd73b987a | TREZIX 16 MG / 320.5 MG / 30 MG Oral Capsule | PSN | 6 | TREZIX™ Capsules | 20220502 |
DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 45c3c2a1-6a89-471e-b6d4-5a4cd73b987a | TREZIX™ Capsules | Proficient Rx LP | 20220502 |
| f90f87cb-77ad-45f4-8b59-09459090d988 | TREZIX™ Capsules | Bryant Ranch Prepack | 20211222 |
| a519a201-bcfd-4029-9bdf-fc3e03f975ac | TREZIX™ Capsules | Wraser Llc | 20210203 |
| e39685de-c542-4cce-bf11-041c4d933061 | National Council for Prescription Drug Programs | 20120724 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | N02BE | Anilides | ATC1-4 | acetaminophen | |
| ATC | N02AA | Natural opium alkaloids | ATC1-4 | dihydrocodeine | |
| ATC | D11AX | Other dermatologicals | ATC1-4 | caffeine | |
| ATC | N06BC | Xanthine derivatives | ATC1-4 | caffeine | |
| FDASPL | D014970 | Xanthines | CHEM | has_chemical_structure | caffeine |
| FDASPL | N0000175739 | Central Nervous System Stimulant | EPC | has_epc | caffeine |
| FDASPL | N0000175790 | Methylxanthine | EPC | has_epc | caffeine |
| FDASPL | N0000175690 | Opioid Agonist | EPC | has_epc | dihydrocodeine |
| FDASPL | N0000175684 | Full Opioid Agonists | MOA | has_moa | dihydrocodeine |
| FDASPL | N0000175729 | Central Nervous System Stimulation | PE | has_pe | caffeine |
| MEDRT | D000082 | Acetaminophen | CHEM | has_ingredient | acetaminophen |
| MEDRT | D002110 | Caffeine | CHEM | has_ingredient | caffeine |
| MEDRT | D003061 | Codeine | CHEM | has_ingredient | dihydrocodeine |
| MEDRT | D003061 | Codeine | CHEM | has_ingredient | dihydrocodeine bitartrate |
| MEDRT | D001049 | Apnea | DISEASE | may_treat | caffeine |
| MEDRT | D001249 | Asthma | DISEASE | ci_with | dihydrocodeine |
| MEDRT | D001249 | Asthma | DISEASE | ci_with | dihydrocodeine bitartrate |
| MEDRT | D002648 | Child | DISEASE | ci_with | dihydrocodeine |
| MEDRT | D002648 | Child | DISEASE | ci_with | dihydrocodeine bitartrate |
| MEDRT | D003371 | Cough | DISEASE | may_treat | dihydrocodeine bitartrate |
| MEDRT | D003371 | Cough | DISEASE | may_treat | dihydrocodeine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | dihydrocodeine bitartrate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | acetaminophen |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | caffeine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | dihydrocodeine |
| MEDRT | D005221 | Fatigue | DISEASE | may_treat | caffeine |
| MEDRT | D005334 | Fever | DISEASE | may_prevent | acetaminophen |
| MEDRT | D005334 | Fever | DISEASE | may_treat | acetaminophen |
| MEDRT | D005955 | Glucosephosphate Dehydrogenase Deficiency | DISEASE | ci_with | acetaminophen |
| MEDRT | D007415 | Intestinal Obstruction | DISEASE | ci_with | dihydrocodeine bitartrate |
| MEDRT | D007415 | Intestinal Obstruction | DISEASE | ci_with | dihydrocodeine |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | acetaminophen |
| MEDRT | D010146 | Pain | DISEASE | may_treat | dihydrocodeine |
| MEDRT | D010146 | Pain | DISEASE | may_treat | acetaminophen |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | acetaminophen |
| MEDRT | D010146 | Pain | DISEASE | may_treat | dihydrocodeine bitartrate |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | dihydrocodeine |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | dihydrocodeine bitartrate |
| MEDRT | D012131 | Respiratory Insufficiency | DISEASE | ci_with | dihydrocodeine |
| MEDRT | D012131 | Respiratory Insufficiency | DISEASE | ci_with | dihydrocodeine bitartrate |
| MEDRT | N0000000133 | Enzyme Inhibitors | MOA | has_moa | caffeine |
| MEDRT | N0000175684 | Full Opioid Agonists | MOA | has_moa | dihydrocodeine |
| MEDRT | N0000175684 | Full Opioid Agonists | MOA | has_moa | dihydrocodeine bitartrate |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | acetaminophen |
| MEDRT | N0000175439 | Analgesia | PE | has_pe | dihydrocodeine bitartrate |
| MEDRT | N0000175439 | Analgesia | PE | has_pe | dihydrocodeine |
| MEDRT | N0000008322 | Bronchodilation | PE | has_pe | caffeine |
| MEDRT | N0000008331 | Cardiovascular Activity Alteration | PE | has_pe | caffeine |
| MEDRT | N0000175724 | Central Nervous System Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000175728 | Central Nervous System Depression | PE | ci_pe | dihydrocodeine bitartrate |
| MEDRT | N0000175728 | Central Nervous System Depression | PE | ci_pe | dihydrocodeine |
| MEDRT | N0000008567 | Decreased Collecting Duct Water Permeability | PE | has_pe | caffeine |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | dihydrocodeine |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | dihydrocodeine bitartrate |
| MEDRT | N0000008836 | Decreased Prostaglandin Production | PE | has_pe | acetaminophen |
| MEDRT | N0000009072 | Hypothalamic Endocrine Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000009197 | Increased Central Nervous System Organized Electrical Activity | PE | has_pe | caffeine |
| MEDRT | N0000175725 | Peripheral Nervous System Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | acetaminophen |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | acetaminophen |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 320.5 MG / 30 MG / 16 MG (expressed as dihydrocodeine bitartrate) |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 3 |
| ATTRIBUTES | TTY | SBD |
| CODES | ANDA | ANDA204785 |
| CODES | MMSL_CODE | BD30013 |
| CODES | RxCUI | 1190201 |
| CODES | SPL_SET_ID | 45c3c2a1-6a89-471e-b6d4-5a4cd73b987a |
| NAMES | Prescribable Synonym | TREZIX 16 MG / 320.5 MG / 30 MG Oral Capsule |
| NAMES | RXNAV_STR | APAP 320.5 MG / Caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix] |
| NAMES | RxNorm Name | acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix] |
| NAMES | RxNorm Synonym | APAP 320.5 MG / Caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix] |
| NAMES | RxNorm Synonym | Trezix (acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG) Oral Capsule |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |